{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:16:17Z","timestamp":1777511777656,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"the Ann Rife Cox Chair in Gynecology, and the Judy Reis\/Al Pisani, MD Ovarian Cancer Research Fund"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5T32-CA101642"],"award-info":[{"award-number":["5T32-CA101642"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"crossref","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1136\/ijgc-2022-003947","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T09:55:15Z","timestamp":1668074115000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00003636","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-8645","authenticated-orcid":false,"given":"Lauren Shore","family":"Prescott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte C.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C.","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9343-8754","authenticated-orcid":false,"given":"Robert L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-003947_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3148.2011.01122.x","article-title":"The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer","volume":"22","author":"De Oliveira","year":"2012","journal-title":"Transfus Med"},{"key":"10.1136\/ijgc-2022-003947_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2005.06.017","article-title":"Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival","volume":"99","author":"Abu-Rustum","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2014.11.009","article-title":"Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database","volume":"136","author":"Prescott","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1245\/s10434-007-9502-9","article-title":"Anemia and transfusions in patients undergoing surgery for cancer","volume":"15","author":"Weber","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0030","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"10","author":"Carson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2022-003947_bb0035","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1012452","article-title":"Liberal or restrictive transfusion in high-risk patients after hip surgery","volume":"365","author":"Carson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003947_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/SLA.0b013e31825b35d5","article-title":"Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis","volume":"256","author":"Acheson","year":"2012","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2022-003947_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2019.03.008","article-title":"Choosing wisely: decreasing the incidence of perioperative blood transfusions in gynecologic oncology","volume":"153","author":"Prescott","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2016.03.010","article-title":"How low should we go: a systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology","volume":"46","author":"Prescott","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1136\/ijgc-2022-003947_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2018.08.040","article-title":"Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian cancer; potential impact of patient blood management on cancer outcomes","volume":"151","author":"Connor","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejogrb.2020.06.013","article-title":"Perioperative blood transfusion and ovarian cancer survival rates: a meta-analysis based on univariate, multivariate and propensity score matched data","volume":"252","author":"Pergialiotis","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2022-003947_bb0065","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/IGC.0b013e3182a57ff6","article-title":"The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer","volume":"23","author":"Altman","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003947_bb0070","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/01.IGC.0000436089.03581.6b","article-title":"The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer","volume":"23","author":"Warner","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003947_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0020-7292(94)90308-5","article-title":"Effect of blood transfusion in patients with gynecologic malignancy","volume":"46","author":"McGehee","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2022-003947_bb0080","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1111\/trf.15552","article-title":"Transfusion of red blood cells does not impact progression-free and overall survival after surgery for ovarian cancer","volume":"59","author":"Hunsicker","year":"2019","journal-title":"Transfusion"},{"key":"10.1136\/ijgc-2022-003947_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.04.327","article-title":"A comparison of postoperative morbidity in open versus robotic-assisted interval debulking surgery for epithelial ovarian cancer patients following neoadjuvant chemotherapy","volume":"154","author":"Zhang","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0090","article-title":"Experts: hospitals can improve care, save health care dollars by cracking down on unnecessary blood transfusions","volume":"25","year":"2013","journal-title":"ED Manag"},{"key":"10.1136\/ijgc-2022-003947_bb0095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ygyno.2013.08.014","article-title":"Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy","volume":"131","author":"Greimel","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003947_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2022-003947_bb0110","author":"Prentice","year":"1992","journal-title":"Introduction to COX (1972) regression models and Life-Tables"},{"key":"10.1136\/ijgc-2022-003947_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1136\/ijgc-2022-003947_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2019.12.006","article-title":"Impact of perioperative red blood cell transfusion on postoperative recovery and long-term outcome in patients undergoing surgery for ovarian cancer: a propensity score-matched analysis","volume":"156","author":"Zhang","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2482-14-34","article-title":"Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis","volume":"14","author":"Luan","year":"2014","journal-title":"BMC Surg"},{"key":"10.1136\/ijgc-2022-003947_bb0135","article-title":"Perioperative blood transfusions and recurrence of colorectal cancer","volume":"2011","author":"Cochrane Colorectal Cancer Group","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2022-003947_bb0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jamcollsurg.2008.11.019","article-title":"Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients","volume":"208","author":"Bernard","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1136\/ijgc-2022-003947_bb0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1423-0410.2012.01626.x","article-title":"Transfusion practice and complications after laparotomy--an observational analysis of a randomized clinical trial","volume":"103","author":"Nielsen","year":"2012","journal-title":"Vox Sang"},{"key":"10.1136\/ijgc-2022-003947_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mpaic.2009.01.017","article-title":"Transfusion-related immunosuppression","volume":"10","author":"Hellings","year":"2009","journal-title":"Anaesth Intensive Care Med"},{"key":"10.1136\/ijgc-2022-003947_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"},{"key":"10.1136\/ijgc-2022-003947_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/bjoc.1999.0883","article-title":"Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy","volume":"82","author":"Barrett-Lee","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2022-003947_bb0165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/fon.11.24","article-title":"Management of anemia in cancer patients","volume":"7","author":"Calabrich","year":"2011","journal-title":"Future Oncol"},{"key":"10.1136\/ijgc-2022-003947_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care","volume":"340","author":"H\u00e9bert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003947_bb0175","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMoa1406617","article-title":"Lower versus higher hemoglobin threshold for transfusion in septic shock","volume":"371","author":"Holst","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003947_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003947_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24008752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24008752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-003947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:41:01Z","timestamp":1753224061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24008752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1048891X24008752"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-003947","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-003947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}